British researchers say they may have developed an improved treatment for prostate cancer using killer viruses.
The Yorkshire-based researchers found how to deliver a specific virus to tumour cells using macrophages – white blood cells.
They have been able to use the low oxygen levels in the tumour cells as a trigger to start the growth of viruses within the tumour.
So far the system has been developed in laboratories at the universities of Sheffield and York and has not been tested on human patients.
They used a virus developed in Sweden as part of a European project directed from York.
The latest research has been published in the journal Cancer Research.
The scientists have also released details of mathematical modelling that has been used to "fine tune" the treatment.
Professor Claire Lewis, of Sheffield University, said: "This new method will make it much easier to treat hard to reach cancers as it uses part of the body’s own immune system to do so."
Fellow researcher Professor Norman Maitland, of York University, said: "While the study is still in the pre-clinical testing stage, it has met all requirements so far for both safety and efficacy, showing a remarkable improvement over current techniques in both the amount of virus used, and the ability to target small disparate tumour deposits."
The Prostate Cancer Charity said the treatment was an "exciting development" and "highly innovative."
Dr Helen Rippon, of the charity added: "It is important to remember however that this technology is still in its infancy and it will still be some time before it reaches men with prostate cancer.”

Leave a Reply